Hyaluronate and Derivatives and Insulin Degludec (U-200) Prefilled Pens
Determining the interaction of Hyaluronate and Derivatives and Insulin Degludec (U-200) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Insulin degludec and liraglutide
- Hyaluronate and Derivatives-Insulin degludec and liraglutide Subcutaneous
- Hyaluronate and Derivatives-Insulin degludec Subcutaneous
- Hyaluronate and Derivatives-Insulin detemir
- Hyaluronate and Derivatives-Insulin Detemir (Cartridges and Prefilled Syringes)
- Hyaluronate and Derivatives-Insulin Detemir (Vials)
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronate and Derivatives Injection (Knee)
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronate sodium Injection
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase and immune globulin
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase and rituximab
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase and trastuzumab